Annual Total Debt
$4.01 B
+$298.60 M+8.05%
31 December 2023
Summary:
Novo Nordisk A/S annual total debt is currently $4.01 billion, with the most recent change of +$298.60 million (+8.05%) on 31 December 2023. During the last 3 years, it has risen by +$2.30 billion (+134.25%). NVO annual total debt is now -1.15% below its all-time high of $4.06 billion, reached on 31 December 2021.NVO Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Debt
$8.53 B
+$342.30 M+4.18%
30 September 2024
Summary:
Novo Nordisk A/S quarterly total debt is currently $8.53 billion, with the most recent change of +$342.30 million (+4.18%) on 30 September 2024. Over the past year, it has increased by +$4.77 billion (+127.05%). NVO quarterly total debt is now at all-time high.NVO Quarterly Total Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVO Total Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +8.1% | +127.0% |
| 3 y3 years | +134.3% | +297.9% |
| 5 y5 years | +4982.4% | +1240.8% |
NVO Total Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -1.1% | +134.3% | at high | +297.9% |
| 5 y | 5 years | -1.1% | +4982.4% | at high | +1305.8% |
| alltime | all time | -1.1% | >+9999.0% | at high |
Novo Nordisk A/S Total Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $8.53 B(+4.2%) |
| June 2024 | - | $8.19 B(+110.3%) |
| Mar 2024 | - | $3.90 B(-2.9%) |
| Dec 2023 | $4.01 B(+8.0%) | $4.01 B(+6.7%) |
| Sept 2023 | - | $3.76 B(+0.2%) |
| June 2023 | - | $3.75 B(+0.4%) |
| Mar 2023 | - | $3.74 B(+0.7%) |
| Dec 2022 | $3.71 B(-8.5%) | $3.71 B(+8.1%) |
| Sept 2022 | - | $3.43 B(-3.9%) |
| June 2022 | - | $3.57 B(-6.6%) |
| Mar 2022 | - | $3.82 B(-5.7%) |
| Dec 2021 | $4.06 B(+137.0%) | $4.06 B(+89.1%) |
| Sept 2021 | - | $2.14 B(-2.6%) |
| June 2021 | - | $2.20 B(+44.7%) |
| Mar 2021 | - | $1.52 B(-11.1%) |
| Dec 2020 | $1.71 B(+154.7%) | $1.71 B(+164.5%) |
| Sept 2020 | - | $647.09 M(+3.5%) |
| June 2020 | - | $624.99 M(+3.0%) |
| Mar 2020 | - | $606.99 M(-9.7%) |
| Dec 2019 | $672.10 M(+751.9%) | $672.10 M(+5.6%) |
| Sept 2019 | - | $636.42 M(-1.3%) |
| June 2019 | - | $644.72 M(-0.6%) |
| Mar 2019 | - | $648.91 M(+722.5%) |
| Dec 2018 | $78.89 M(-71.1%) | $78.89 M(+50.5%) |
| Sept 2018 | - | $52.43 M(+36.9%) |
| June 2018 | - | $38.31 M(+1.6%) |
| Mar 2018 | - | $37.69 M(-86.2%) |
| Dec 2017 | $272.99 M(+738.3%) | $272.99 M(+563.4%) |
| Sept 2017 | - | $41.15 M(-84.1%) |
| June 2017 | - | $258.90 M(+194.0%) |
| Mar 2017 | - | $88.06 M(+170.4%) |
| Dec 2016 | $32.57 M(-79.3%) | $32.57 M(-52.5%) |
| Sept 2016 | - | $68.63 M(+13.1%) |
| June 2016 | - | $60.71 M(-1.7%) |
| Mar 2016 | - | $61.73 M(-60.7%) |
| Dec 2015 | $157.17 M(+33.7%) | $157.17 M(+65.4%) |
| Sept 2015 | - | $95.03 M(-14.1%) |
| June 2015 | - | $110.64 M(+28.5%) |
| Mar 2015 | - | $86.11 M(-26.7%) |
| Dec 2014 | $117.55 M(+195.4%) | $117.55 M(+142.8%) |
| Sept 2014 | - | $48.41 M(-34.8%) |
| June 2014 | - | $74.28 M(-49.8%) |
| Mar 2014 | - | $148.04 M(+272.0%) |
| Dec 2013 | $39.79 M(-55.1%) | $39.79 M(-67.2%) |
| Sept 2013 | - | $121.22 M(-3.1%) |
| June 2013 | - | $125.11 M(+142.6%) |
| Mar 2013 | - | $51.56 M(-41.8%) |
| Dec 2012 | $88.62 M(-40.4%) | $88.62 M(-53.1%) |
| Sept 2012 | - | $188.91 M(+26.8%) |
| June 2012 | - | $148.95 M(-6.9%) |
| Mar 2012 | - | $159.98 M(+7.6%) |
| Dec 2011 | $148.64 M(-62.5%) | $148.64 M(-62.9%) |
| Sept 2011 | - | $400.43 M(+48.6%) |
| June 2011 | - | $269.55 M(-5.8%) |
| Mar 2011 | - | $286.21 M(-27.9%) |
| Dec 2010 | $396.74 M(+48.6%) | $396.74 M(+8.7%) |
| Sept 2010 | - | $364.87 M(-48.1%) |
| June 2010 | - | $703.55 M(+93.5%) |
| Mar 2010 | - | $363.53 M(+36.2%) |
| Dec 2009 | $266.97 M(-38.7%) | $266.97 M(+13.8%) |
| Sept 2009 | - | $234.53 M(-13.1%) |
| June 2009 | - | $269.90 M(-38.3%) |
| Mar 2009 | - | $437.49 M(+0.4%) |
| Dec 2008 | $435.66 M(+63.2%) | $435.66 M(+29.6%) |
| Sept 2008 | - | $336.08 M(+14.2%) |
| June 2008 | - | $294.17 M(-10.1%) |
| Mar 2008 | - | $327.10 M(+22.5%) |
| Dec 2007 | $267.02 M(-0.3%) | $267.02 M(+8.6%) |
| Sept 2007 | - | $245.86 M(+7.4%) |
| June 2007 | - | $229.00 M(-6.5%) |
| Mar 2007 | - | $245.00 M(-8.5%) |
| Dec 2006 | $267.85 M(-37.3%) | $267.85 M(+6.3%) |
| Sept 2006 | - | $252.00 M(-2.2%) |
| June 2006 | - | $257.78 M(-33.7%) |
| Mar 2006 | - | $388.57 M(-9.0%) |
| Dec 2005 | $427.00 M(+37.4%) | $427.00 M(+24.6%) |
| Sept 2005 | - | $342.81 M(+13.3%) |
| June 2005 | - | $302.57 M(+3.9%) |
| Mar 2005 | - | $291.16 M(-6.3%) |
| Dec 2004 | $310.69 M | $310.69 M(+56.9%) |
| Sept 2004 | - | $198.05 M(-0.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2004 | - | $198.78 M(-22.9%) |
| Mar 2004 | - | $257.83 M(-12.0%) |
| Dec 2003 | $293.01 M(+49.6%) | $293.01 M(>+9900.0%) |
| Sept 2003 | - | $0.00(0.0%) |
| June 2003 | - | $0.00(0.0%) |
| Mar 2003 | - | $0.00(-100.0%) |
| Dec 2002 | $195.83 M(-2.1%) | $195.83 M(>+9900.0%) |
| Sept 2002 | - | $0.00(0.0%) |
| June 2002 | - | $0.00(0.0%) |
| Mar 2002 | - | $0.00(-100.0%) |
| Dec 2001 | $199.99 M(-9.1%) | $199.99 M(>+9900.0%) |
| Sept 2001 | - | $0.00(0.0%) |
| June 2001 | - | $0.00(0.0%) |
| Mar 2001 | - | $0.00(-100.0%) |
| Dec 2000 | $220.02 M(-18.6%) | $220.02 M(>+9900.0%) |
| Sept 2000 | - | $0.00(0.0%) |
| June 2000 | - | $0.00(0.0%) |
| Mar 2000 | - | $0.00(-100.0%) |
| Dec 1999 | $270.41 M(-37.4%) | $270.41 M(>+9900.0%) |
| Sept 1999 | - | $0.00(0.0%) |
| June 1999 | - | $0.00(0.0%) |
| Mar 1999 | - | $0.00(-100.0%) |
| Dec 1998 | $431.97 M(-5.1%) | $431.97 M(>+9900.0%) |
| Sept 1998 | - | $0.00(0.0%) |
| June 1998 | - | $0.00(0.0%) |
| Mar 1998 | - | $0.00(-100.0%) |
| Dec 1997 | $455.16 M(+17.7%) | $455.16 M(>+9900.0%) |
| Sept 1997 | - | $0.00(0.0%) |
| June 1997 | - | $0.00(0.0%) |
| Mar 1997 | - | $0.00(-100.0%) |
| Dec 1996 | $386.59 M(+4.9%) | $386.59 M(>+9900.0%) |
| Sept 1996 | - | $0.00(0.0%) |
| June 1996 | - | $0.00(0.0%) |
| Mar 1996 | - | $0.00(-100.0%) |
| Dec 1995 | $368.70 M(-50.8%) | $368.70 M(>+9900.0%) |
| Sept 1995 | - | $0.00(0.0%) |
| June 1995 | - | $0.00(0.0%) |
| Mar 1995 | - | $0.00(-100.0%) |
| Dec 1994 | $750.04 M(+18.0%) | $750.04 M(>+9900.0%) |
| Sept 1994 | - | $0.00(0.0%) |
| June 1994 | - | $0.00(0.0%) |
| Mar 1994 | - | $0.00(-100.0%) |
| Dec 1993 | $635.74 M(+11.0%) | $635.74 M(>+9900.0%) |
| Sept 1993 | - | $0.00(0.0%) |
| June 1993 | - | $0.00(0.0%) |
| Mar 1993 | - | $0.00(-100.0%) |
| Dec 1992 | $572.85 M(+10.3%) | $572.85 M(>+9900.0%) |
| Sept 1992 | - | $0.00(0.0%) |
| June 1992 | - | $0.00(0.0%) |
| Mar 1992 | - | $0.00(-100.0%) |
| Dec 1991 | $519.31 M(+5.0%) | $519.31 M(>+9900.0%) |
| Sept 1991 | - | $0.00(0.0%) |
| June 1991 | - | $0.00(0.0%) |
| Mar 1991 | - | $0.00(-100.0%) |
| Dec 1990 | $494.69 M(-3.0%) | $494.69 M(>+9900.0%) |
| Sept 1990 | - | $0.00(0.0%) |
| June 1990 | - | $0.00(0.0%) |
| Mar 1990 | - | $0.00(-100.0%) |
| Dec 1989 | $510.00 M(+67.0%) | $510.00 M(>+9900.0%) |
| Sept 1989 | - | $0.00(0.0%) |
| June 1989 | - | $0.00(0.0%) |
| Mar 1989 | - | $0.00(-100.0%) |
| Dec 1988 | $305.36 M(-3.2%) | $305.36 M(>+9900.0%) |
| Sept 1988 | - | $0.00(0.0%) |
| June 1988 | - | $0.00(0.0%) |
| Mar 1988 | - | $0.00(-100.0%) |
| Dec 1987 | $315.48 M(+136.0%) | $315.48 M(>+9900.0%) |
| Sept 1987 | - | $0.00(0.0%) |
| June 1987 | - | $0.00(0.0%) |
| Mar 1987 | - | $0.00(-100.0%) |
| Dec 1986 | $133.66 M(+49.8%) | $133.66 M(>+9900.0%) |
| Sept 1986 | - | $0.00(0.0%) |
| June 1986 | - | $0.00(0.0%) |
| Mar 1986 | - | $0.00(-100.0%) |
| Dec 1985 | $89.24 M(-34.8%) | $89.24 M(>+9900.0%) |
| Sept 1985 | - | $0.00(0.0%) |
| June 1985 | - | $0.00(0.0%) |
| Mar 1985 | - | $0.00(-100.0%) |
| Dec 1984 | $136.84 M | $136.84 M(>+9900.0%) |
| Sept 1984 | - | $0.00(0.0%) |
| June 1984 | - | $0.00(0.0%) |
| Mar 1984 | - | $0.00 |
FAQ
- What is Novo Nordisk A/S annual total debt?
- What is the all time high annual total debt for Novo Nordisk A/S?
- What is Novo Nordisk A/S annual total debt year-on-year change?
- What is Novo Nordisk A/S quarterly total debt?
- What is the all time high quarterly total debt for Novo Nordisk A/S?
- What is Novo Nordisk A/S quarterly total debt year-on-year change?
What is Novo Nordisk A/S annual total debt?
The current annual total debt of NVO is $4.01 B
What is the all time high annual total debt for Novo Nordisk A/S?
Novo Nordisk A/S all-time high annual total debt is $4.06 B
What is Novo Nordisk A/S annual total debt year-on-year change?
Over the past year, NVO annual total debt has changed by +$298.60 M (+8.05%)
What is Novo Nordisk A/S quarterly total debt?
The current quarterly total debt of NVO is $8.53 B
What is the all time high quarterly total debt for Novo Nordisk A/S?
Novo Nordisk A/S all-time high quarterly total debt is $8.53 B
What is Novo Nordisk A/S quarterly total debt year-on-year change?
Over the past year, NVO quarterly total debt has changed by +$4.77 B (+127.05%)